Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Tricida, Inc.
*STREET
7000 Shoreline Court, Suite 201
*CITY
South San Francisco
*STATE
(Required for U.S. applicants)
California
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94080
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for
the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the
treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:87931649
Filing Date:05/22/2018
To the Commissioner for Trademarks:
MARK: TRICIDA (Standard Characters, see mark)
The literal element of the mark consists of TRICIDA.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Tricida, Inc., a corporation of Delaware, having an address of
7000 Shoreline Court, Suite 201
South San Francisco, California 94080
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical
preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical
preparations for the treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal
disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Attorney Information:
Katherine A. Keating and Jill Chalmers, Katherine Green of Bryan Cave Leighton Paisner LLP Three Embarcadero Center, 7th
Floor
San Francisco, California 94111
United States
415-675-3400(phone)
415-675-3434(fax)
katherine.keating@bclplaw.com (authorized)
The attorney docket/reference number is 0560044.
The applicant's current Correspondence Information:
Katherine A. Keating
Bryan Cave Leighton Paisner LLP
Three Embarcadero Center, 7th Floor
San Francisco, California 94111
415-675-3400(phone)
415-675-3434(fax)
katherine.keating@bclplaw.com;katherine.green@bclplaw.com; sftmdocketing@bclplaw.com; joel.rayala@bclplaw.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Edward J. Hejlek/ Date: 05/22/2018
Signatory's Name: Edward Hejlek
Signatory's Position: General Counsel & Sr. VP
Payment Sale Number: 87931649
Payment Accounting Date: 05/23/2018
Serial Number: 87931649
Internet Transmission Date: Tue May 22 15:09:47 EDT 2018
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XX-20180522150947085
107-87931649-610601c7cdcc112f0a8d33e8baf
a6794b58c4f38876c83544c0e70d52b7791763a-
DA-1454-20180522144107079277